Awareness of Obesity Among Patients With Psoriasis
abstract
This abstract is available on the publisher's site.
Access this abstract nowChronic plaque psoriasis is frequently associated with metabolic comorbidities, including obesity that have an important impact on the disease. A Mendelian randomization analysis showed that obesity is a risk factor for the development of psoriasis and psoriatic arthritis. Moreover, obesity is associated with greater psoriasis severity and a reduced response to systemic treatments. Conversely, loss of the excess weight through low calorie diet and/or bariatric surgery improves the response to systemic pharmacological treatments and improves the patient's metabolic profile. Losing weight is recommended for all obese patients, and understanding if obese patients with psoriasis are aware of the importance of addressing obesity and are interested in accepting a diet regimen might have important implications in daily practice. The objective of the study was to evaluate the patients' awareness of the negative effect of overweight/ obesity on their general health and on psoriasis, and their motivation to lose excess weight. This was a survey based on a structured questionnaire, designed ad hoc with the help of nutritionists. Consecutive patients attending the Divisions of Dermatology at multiple hospitals in Italy between 1 April and 1 July 2022 were considered eligible. Inclusion criteria were age ≥18 years, clinical diagnosis of moderate-to-severe chronic plaque psoriasis and body mass index (BMI) ≥25 and willingness to participate in the survey. Exclusion criteria were the actual participation to a weight-loss programme with a nutritionist/dietician. Sociodemographic and clinical variables were collected. The study was approved by the local Ethical committees and patients provided written informed consent (Protocol n. 0146095).
Click on any of these tags to subscribe to Topic Alerts. Once subscribed, you can get a single, daily email any time PracticeUpdate publishes content on the topics that interest you.
Visit your Preferences and Settings section to Manage All Topic Alerts
Additional Info
Disclosure statements are available on the authors' profiles:
Awareness of obesity among patients with psoriasis
J Eur Acad Dermatol Venereol 2023 Nov 01;[EPub Ahead of Print], F Bellinato, P Gisondi, A Balato, G Caldarola, E Cammarata, E Campione, A Carugno, A Conti, M Corazza, P Dapavo, A Dattola, V Di Lernia, M Gasperini, S Panduri, F Prignano, F Satolli, E Spisni, G GirolomoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.